SUPPLEMENT

Q3 2022 — Financial statements (US GAAP)

Q3 2022PDF · 8 pages116 KB
ASML - Summary US GAAP Consolidated Statements of Operations
Three months ended, Nine months ended,
Oct 3, Oct 2, Oct 3, Oct 2,
(unaudited, in millions €, except per share data) 2021 2022 2021 2022
Net system sales 4,111.1 4,254.7 10,189.6 10,682.4
Net service and field option sales 1,130.2 1,523.6 3,435.8 4,060.8
Total net sales 5,241.3 5,778.3 13,625.4 14,743.2
Total cost of sales (2,529.9) (2,784.6) (6,517.0) (7,354.0)
Gross profit 2,711.4 2,993.7 7,108.4 7,389.2
Research and development costs (609.2) (819.4) (1,866.4) (2,347.2)
Selling, general and administrative costs (182.9) (235.8) (523.1) (665.5)
Income from operations 1,919.3 1,938.5 4,718.9 4,376.5
Interest and other, net (10.5) (15.1) (32.4) (41.5)
Income before income taxes 1,908.8 1,923.4 4,686.5 4,335.0
Income tax expense (270.9) (252.0) (705.4) (612.6)
Income after income taxes 1,637.9 1,671.4 3,981.1 3,722.4
Profit related to equity method investments 102.3 30.1 128.7 85.3
Net income 1,740.2 1,701.5 4,109.8 3,807.7
Basic net income per ordinary share 4.27 4.29 9.99 9.53
Diluted net income per ordinary share 4.26 4.29 9.97 9.52
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 407.9 396.2 411.6 399.6
Diluted 408.6 396.6 412.2 399.9
ASML - Ratios and Other Data
Three months ended, Nine months ended,
Oct 3, Oct 2, Oct 3, Oct 2,
(unaudited, in millions €, except otherwise indicated) 2021 2022 2021 2022
Gross profit as a percentage of net sales 51.7 % 51.8 % 52.2 % 50.1 %
Income from operations as a percentage of net sales 36.6 % 33.5 % 34.6 % 29.7 %
Net income as a percentage of net sales 33.2 % 29.4 % 30.2 % 25.8 %
Income taxes as a percentage of income before income taxes 14.2 % 13.1 % 15.1 % 14.1 %
Shareholders’ equity as a percentage of total assets 42.1 % 24.3 % 42.1 % 24.3 %
Sales of lithography systems (in units) 1 79 86 227 239
Value of booked systems (EUR millions) 2 6,179 8,920 19,190 24,358
Net bookings lithography systems (in units) 1, 2 178 150 465 452
Number of payroll employees in FTEs 29,025 34,720 29,025 34,720
Number of temporary employees in FTEs 1,659 2,875 1,659 2,875
1. Lithography systems do not include metrology and inspection systems.
2. Net bookings include all system sales orders for which written authorizations have been accepted.

-- 1 of 8 --

ASML - Summary US GAAP Consolidated Balance Sheets
Dec 31, Oct 2,
(unaudited, in millions €) 2021 2022
ASSETS
Cash and cash equivalents 6,951.8 3,152.8
Short-term investments 638.5 210.0
Accounts receivable, net 3,028.0 5,840.2
Finance receivables, net 1,185.6 1,399.4
Current tax assets 42.0 305.6
Contract assets 164.6 276.9
Inventories, net 5,179.2 6,884.0
Other assets 1,000.5 1,657.5
Total current assets 18,190.2 19,726.4
Finance receivables, net 383.0 174.9
Deferred tax assets 1,098.7 1,599.6
Loan receivable 124.4 364.4
Other assets 887.0 745.2
Equity method investments 892.5 998.7
Goodwill 4,555.6 4,555.6
Other intangible assets, net 952.1 870.1
Property, plant and equipment, net 2,982.7 3,561.7
Right-of-use assets - Operating 159.5 203.8
Right-of-use assets - Finance 5.3 3.1
Total non-current assets 12,040.8 13,077.1
Total assets 30,231.0 32,803.5
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities 12,298.0 15,668.6
Total current liabilities 12,298.0 15,668.6
Long-term debt 4,075.0 3,503.1
Deferred and other tax liabilities 240.6 283.0
Contract liabilities 3,225.7 4,918.6
Accrued and other liabilities 251.1 475.1
Total non-current liabilities 7,792.4 9,179.8
Total liabilities 20,090.4 24,848.4
Total shareholders’ equity 10,140.6 7,955.1
Total liabilities and shareholders’ equity 30,231.0 32,803.5

-- 2 of 8 --

ASML - Summary US GAAP Consolidated Statements of Cash Flows
Three months ended, Nine months ended,
Oct 3, Oct 2, Oct 3, Oct 2,
(unaudited, in millions €) 2021 2022 2021 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 1,740.2 1,701.5 4,109.8 3,807.7
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 116.2 137.9 346.8 400.4
Impairment and loss (gain) on disposal (39.8) 13.2 (33.4) 25.6
Share-based compensation expense 34.0 22.5 84.0 47.9
Inventory reserves 52.9 81.8 131.3 207.2
Deferred tax expense (benefit) (270.1) (340.8) (313.4) (475.2)
Equity method investments (97.3) (36.8) (141.2) (105.5)
Changes in assets and liabilities 265.5 (409.8) 244.9 (771.8)
Net cash provided by (used in) operating activities 1,801.6 1,169.5 4,428.8 3,136.3
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (197.0) (356.6) (627.5) (828.2)
Purchase of intangible assets (7.9) (7.7) (22.2) (25.2)
Purchase of short-term investments (50.0) (104.1) (658.5) (330.1)
Maturity of short-term investments 99.7 199.5 1,823.7 758.6
Loans issued and other investments (124.4) (240.0) (124.4) (240.0)
Proceeds from sale of subsidiaries (net of cash disposed) — — 12.9 —
Net cash provided by (used in) investing activities (279.6) (508.9) 404.1 (664.9)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid — (543.5) (639.1) (2,018.7)
Purchase of treasury shares (2,401.6) (1,087.9) (5,953.1) (4,304.7)
Net proceeds from issuance of shares 12.3 19.9 36.9 62.9
Net proceeds from issuance of notes, net of issuance costs — — — 495.6
Repayment of debt and finance lease obligations (2.6) (1.2) (9.4) (515.4)
Net cash provided by (used in) financing activities (2,391.9) (1,612.7) (6,564.7) (6,280.3)
Net cash flows (869.9) (952.1) (1,731.8) (3,808.9)
Effect of changes in exchange rates on cash 2.0 8.4 1.1 9.9
Net increase (decrease) in cash and cash equivalents (867.9) (943.7) (1,730.7) (3,799.0)
Cash and cash equivalents at beginning of the period 5,186.6 4,096.5 6,049.4 6,951.8
Cash and cash equivalents at end of the period 4,318.7 3,152.8 4,318.7 3,152.8

-- 3 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Statements of
Operations
Three months ended,
Oct 3, Dec 31, Apr 3, Jul 3, Oct 2,
(unaudited, in millions €, except per share data) 2021 2021 2022 2022 2022
Net system sales 4,111.1 3,463.2 2,287.2 4,140.5 4,254.7
Net service and field option sales 1,130.2 1,522.4 1,247.2 1,290.0 1,523.6
Total net sales 5,241.3 4,985.6 3,534.4 5,430.5 5,778.3
Total cost of sales (2,529.9) (2,285.0) (1,803.4) (2,766.0) (2,784.6)
Gross profit 2,711.4 2,700.6 1,731.0 2,664.5 2,993.7
Research and development costs (609.2) (680.6) (738.7) (789.1) (819.4)
Selling, general and administrative costs (182.9) (202.5) (207.7) (222.0) (235.8)
Other income 1 — 213.7 — — —
Income from operations 1,919.3 2,031.2 784.6 1,653.4 1,938.5
Interest and other, net (10.5) (12.2) (15.6) (10.8) (15.1)
Income before income taxes 1,908.8 2,019.0 769.0 1,642.6 1,923.4
Benefit from (provision for) income taxes (270.9) (316.0) (114.4) (246.2) (252.0)
Income after income taxes 1,637.9 1,703.0 654.6 1,396.4 1,671.4
Profit related to equity method investments 102.3 70.4 40.7 14.5 30.1
Net income 1,740.2 1,773.4 695.3 1,410.9 1,701.5
Basic net income per ordinary share 4.27 4.39 1.73 3.54 4.29
Diluted net income per ordinary share 4.26 4.38 1.73 3.54 4.29
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic 407.9 404.3 401.1 398.3 396.2
Diluted 408.6 405.0 401.5 398.6 396.6
ASML - Quarterly Summary Ratios and other data
Oct 3, Dec 31, Apr 3, Jul 3, Oct 2,
(unaudited, in millions €, except otherwise indicated) 2021 2021 2022 2022 2022
Gross profit as a percentage of net sales 51.7 % 54.2 % 49.0 % 49.1 % 51.8 %
Income from operations as a percentage of net sales 36.6 % 40.7 % 22.2 % 30.4 % 33.5 %
Net income as a percentage of net sales 33.2 % 35.6 % 19.7 % 26.0 % 29.4 %
Income taxes as a percentage of income before income taxes 14.2 % 15.7 % 14.9 % 15.0 % 13.1 %
Shareholders’ equity as a percentage of total assets 42.1 % 33.5 % 29.1 % 24.0 % 24.3 %
Sales of lithography systems (in units) 2 79 82 62 91 86
Value of booked systems (EUR millions) 3 6,179 7,050 6,977 8,461 8,920
Net bookings lithography systems (in units) 2, 3 178 191 163 139 150
Number of payroll employees in FTEs 29,025 29,861 30,861 32,627 34,720
Number of temporary employees in FTEs 1,659 2,155 2,329 2,689 2,875
1. Other income includes the gain on sale of Berliner Glas subsidiaries.
2. Lithography systems do not include metrology and inspection systems.
3. Net bookings include all system sales orders for which written authorizations have been accepted.

-- 4 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Balance Sheets
Oct 3, Dec 31, Apr 3, Jul 3, Oct 2,
(unaudited, in millions €) 2021 2021 2022 2022 2022
ASSETS
Cash and cash equivalents 4,318.7 6,951.8 4,324.1 4,096.5 3,152.8
Short-term investments 137.0 638.5 398.5 305.4 210.0
Accounts receivable, net 3,383.3 3,028.0 3,494.6 5,376.7 5,840.2
Finance receivables, net 1,185.9 1,185.6 1,267.6 1,233.1 1,399.4
Current tax assets 289.5 42.0 811.0 658.0 305.6
Contract assets 272.0 164.6 371.3 270.4 276.9
Inventories, net 4,944.2 5,179.2 6,073.5 6,367.1 6,884.0
Other assets 995.0 1,000.5 1,468.2 1,528.1 1,657.5
Held for sale assets 152.7 — — — —
Total current assets 15,678.3 18,190.2 18,208.8 19,835.3 19,726.4
Finance receivables, net 139.0 383.0 191.5 — 174.9
Deferred tax assets 986.0 1,098.7 1,141.9 1,240.8 1,599.6
Loan receivable 124.4 124.4 124.4 124.4 364.4
Other assets 996.5 887.0 809.8 752.9 745.2
Equity method investments 963.2 892.5 940.0 961.4 998.7
Goodwill 4,555.6 4,555.6 4,555.6 4,555.6 4,555.6
Other intangible assets, net 963.8 952.1 923.4 896.1 870.1
Property, plant and equipment, net 2,730.3 2,982.7 3,159.4 3,357.7 3,561.7
Right-of-use assets - Operating 155.0 159.5 172.5 184.6 203.8
Right-of-use assets - Finance 5.9 5.3 4.5 3.8 3.1
Total non-current assets 11,619.7 12,040.8 12,023.0 12,077.3 13,077.1
Total assets 27,298.0 30,231.0 30,231.8 31,912.6 32,803.5
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities 9,114.7 12,298.0 13,612.8 14,637.0 15,668.6
Held for sale liabilities 47.9 — — — —
Total current liabilities 9,162.6 12,298.0 13,612.8 14,637.0 15,668.6
Long-term debt 4,105.8 4,075.0 3,951.7 4,385.3 3,503.1
Deferred and other tax liabilities 282.6 240.6 262.2 252.4 283.0
Contract liabilities 2,001.7 3,225.7 3,292.2 4,630.6 4,918.6
Accrued and other liabilities 242.9 251.1 302.5 358.7 475.1
Total non-current liabilities 6,633.0 7,792.4 7,808.6 9,627.0 9,179.8
Total liabilities 15,795.6 20,090.4 21,421.4 24,264.0 24,848.4
Total shareholders’ equity 11,502.4 10,140.6 8,810.4 7,648.6 7,955.1
Total liabilities and shareholders’ equity 27,298.0 30,231.0 30,231.8 31,912.6 32,803.5

-- 5 of 8 --

ASML - Quarterly Summary US GAAP Consolidated Statements of Cash
Flows
Three months ended,
Oct 3, Dec 31, Apr 3, Jul 3, Oct 2,
(unaudited, in millions €) 2021 2021 2022 2022 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 1,740.2 1,773.4 695.3 1,410.9 1,701.5
Adjustments to reconcile net income to net cash flows from
operating activities:
Depreciation and amortization 116.2 124.2 131.0 131.5 137.9
Impairment and loss (gain) on disposal (39.8) 17.5 12.1 0.3 13.2
Share-based compensation expense 34.0 33.5 11.5 13.9 22.5
Gain on sale of subsidiaries — (213.7) — — —
Inventory reserves 52.9 49.4 50.2 75.2 81.8
Deferred tax expense (benefit) (270.1) (106.2) (39.7) (94.7) (340.8)
Equity method investments (97.3) 91.4 (47.5) (21.2) (36.8)
Changes in assets and liabilities 265.5 4,647.5 (1,399.0) 1,037.0 (409.8)
Net cash provided by (used in) operating activities 1,801.6 6,417.0 (586.1) 2,552.9 1,169.5
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (197.0) (273.2) (240.1) (231.5) (356.6)
Purchase of intangible assets (7.9) (17.5) (11.5) (6.0) (7.7)
Purchase of short-term investments (50.0) (504.2) (19.6) (206.4) (104.1)
Maturity of short-term investments 99.7 2.7 259.5 299.6 199.5
Loans issued and other investments (124.4) — — — (240.0)
Proceeds from sale of subsidiaries (net of cash disposed) — 316.1 — — —
Net cash provided by (used in) investing activities (279.6) (476.1) (11.7) (144.3) (508.9)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid — (729.2) — (1,475.3) (543.5)
Purchase of treasury shares (2,401.6) (2,607.2) (2,038.2) (1,178.5) (1,087.9)
Net proceeds from issuance of shares 12.3 12.0 21.5 21.5 19.9
Net proceeds from issuance of notes, net of issuance costs — — — 495.6 —
Repayment of debt and finance lease obligations (2.6) (2.6) (13.5) (500.7) (1.2)
Net cash provided by (used in) financing activities (2,391.9) (3,327.0) (2,030.2) (2,637.4) (1,612.7)
Net cash flows (869.9) 2,613.9 (2,628.0) (228.8) (952.1)
Effect of changes in exchange rates on cash 2.0 19.2 0.3 1.2 8.4
Net increase (decrease) in cash and cash equivalents (867.9) 2,633.1 (2,627.7) (227.6) (943.7)
Cash and cash equivalents at beginning of the period 5,186.6 4,318.7 6,951.8 4,324.1 4,096.5
Cash and cash equivalents at end of the period 4,318.7 6,951.8 4,324.1 4,096.5 3,152.8

-- 6 of 8 --

Notes to the Summary US GAAP Consolidated Financial Statements
Basis of preparation
The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the
accounting principles generally accepted in the United States of America ("US GAAP").
For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these
interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial
Statements and Notes included within our 2021 Annual Report based on US GAAP, which is available on www.asml.com.

-- 7 of 8 --

Forward Looking Statements
This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995, including statements with respect to expected trends, including trends in end markets
and technology industry and business environment trends, supply chain constraints and plan to add capacity and capacity
goals, outlook and expected financial results, including bookings and orders, expected net sales, gross margin, R&D costs,
SG&A costs and estimated annualized effective tax rate and full year 2022 expectations for net sales and gross margin and
expected shipments in 2023, statements with respect to fast shipments and impact on expected results, gross margin ambition,
statements made at our 2021 Investor Day including revenue and gross margin opportunity for 2025 and growth opportunities
beyond 2025, expected annual revenue growth rate for the period of 2020-2030, and our plan to revisit the expectations
presented at the 2021 Investor Day, estimates of amounts of deferred revenue not yet recognized and timing of recognition of
such deferred revenue for fast shipments, including value of fast shipments in 2022 leading to deferred revenue recognition,
expected shipments, plans and strategies, impact of gas shortage on us and suppliers, customer demand trends, statements
about the market and macroeconomic trends and concerns regarding inflation and consumer confidence, statements with
respect to dividends including the Q3 dividend and share buybacks and financial policy including statements with respect to
share buyback programs, aim to improve ESG sustainability KPI's and other non-historical statements. You can generally identify
these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan",
"estimate", "forecast", "potential", "intend", "continue", "target", "future", "progress", "goal" and variations of these words or
comparable words. These statements are not historical facts, but rather are based on current expectations, estimates,
assumptions and projections about our business and our future financial results and readers should not place undue reliance on
them. Forward-looking statements do not guarantee future performance and involve a number of substantial known and
unknown risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand
and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors,
the impact of general economic conditions including the impact of the current macroeconomic uncertainty in the market, inflation
and consumer confidence which could potentially lead to a recession, demand for our customers’ products, performance of our
systems, the impact of the COVID-19 outbreak and measures taken to contain it on us, our suppliers, the global economy and
financial markets, the impact of the Russian military actions in the Ukraine and measures taken in response on the global
economy and global financial markets and other factors that may impact ASML’s financial results, including customer demand
and ASML’s ability to obtain parts and components for its products and otherwise meet demand, the success of technology
advances and the pace of new product development and customer acceptance of and demand for new products, production
capacity and our ability to increase capacity to meet demand, the impact of inflation, the number and timing of systems ordered,
shipped and recognized in revenue, and the risk of order cancellation or push out, supply chain capacity and constraints and
logistics and constraints on our ability to produce systems to meet demand, the timing of recognition of deferred revenue from
fast shipments and impact on our results, the impact of the gas shortage on us and our suppliers, trends in the semi-conductor
industry, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes
and litigation, availability of raw materials, critical manufacturing equipment and qualified employees, trade environment, import/
export and national security regulations and orders and their impact on us including the impact of the new US export regulations
which we are continuing to assess, changes in exchange and tax rates, available liquidity and liquidity requirements, our ability to
refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and
share repurchases, results of the share repurchase programs and other risks indicated in the risk factors included in ASML’s
Annual Report on Form 20-F for the year ended December 31, 2021 and other filings with and submissions to the US Securities
and Exchange Commission. These forward-looking statements are made only as of the date of this document. We undertake no
obligation to update any forward-looking statements after the date of this report or to conform such statements to actual results
or revised expectations, except as required by law.

-- 8 of 8 --